Heart rate and diastolic arterial pressure in cardiac arrest patients: A nationwide, multicenter prospective registry.

BACKGROUND: Guidelines have recommended monitoring mean arterial pressure (MAP) and systolic arterial pressure (SAP) in cardiac arrest patients, but there has been relatively little regard for diastolic arterial pressure (DAP) and heart rate (HR). We aimed to determine the prognostic significance of hemodynamic parameters at all time points during targeted temperature management (TTM).
METHODS: We reviewed the SAP, DAP, MAP, and HR data in out-of-hospital cardiac arrest (OHCA) survivors from the prospective multicenter registry of 22 teaching hospitals. This study included 1371 patients who underwent TTM among 10,258 cardiac arrest patients. The hemodynamic parameters were recorded every 6 hours from the return of spontaneous circulation (ROSC) to 4 days. The risks of those according to time points during TTM were compared.
RESULTS: Of the included patients, 943 (68.8%) had poor neurological outcomes. The predictive ability of DAP surpassed that of SAP and MAP at all time points, and among the hemodynamic variables HR/DAP was the best predictor of the poor outcome. The risks in patients with DAP < 55 to 70 mmHg and HR > 70 to 100 beats/min were steeply increased for 2 days after ROSC and correlated with the poor outcome at all time points. Bradycardia showed lower risks only at 6 hours to 24 hours after ROSC.
CONCLUSION: Hemodynamic parameters should be intensively monitored especially for 2 days after ROSC because cardiac arrest patients may be vulnerable to hemodynamic instability during TTM. Monitoring HR/DAP can help access the risks in cardiac arrest patients.

Introduction

Hemodynamic monitoring is essential in cardiac arrest patients and hemodynamic parameters such as systolic arterial pressure (SAP) and mean arterial pressure (MAP) have been primarily used for hemodynamic monitoring as recommended in the most recent guidelines for cardiac arrest patients [1]. Furthermore, most studies on hypotension episodes in cardiac arrest patients have been studied with MAP or SAP for neuroprognostication [2]. However, two studies demonstrated that DAP in the early phase of admission can be superior to SAP or MAP for neuroprognostication in cardiac arrest patients [3, 4]. Unfortunately, the evidence of these studies remains weak because they were not multi-center large-scale studies and had small populations. Moreover, the authors only investigated the hemodynamic data within 6 hours.

Diastolic arterial pressure (DAP) is being proposed as a promising prognostic tool in addition to SAP or MAP. DAP may be as available as SAP to assess the prognosis or risks in septic shock that can be mixed with hypovolemic, cardiogenic, and distributive shock [5, 6]. Another study revealed that DAP is superior to SAP in evaluating the prognosis of cardiogenic shock [7]. The role of DAP for risk assessment in cardiac arrest patients requires new consideration as hypotension during cardiac arrest can result from a number of different mechanisms.

Additionally, HR is another hemodynamic variable that could serve as a risk factor in cardiac arrest patients [8]. Hypotension is compensated for by increased sympathetic activity during hemorrhagic shock and acute critical illness [9, 10], and eventually HR increases in accordance with increased sympathetic activity. As a reflection of this compensatory mechanism, the shock index (HR/SAP), modified shock index (HR/MAP), and diastolic shock index (HR/DAP) have been used to predict prognosis in various diseases [5, 11]; however, the diastolic shock index has never been compared with other hemodynamic parameters in cardiac arrest patients. Also, the significance of DAPs during an entire time window of targeted temperature management (TTM) has never been debated.

The primary aim of this study was to explore the neuroprognostic significance of certain hemodynamic variables such as HR and DAP in comparison with SAP and MAP and their respective shock indices in survivors of out-of-hospital cardiac arrest (OHCA) during the post- return of spontaneous circulation (ROSC) phase.

Materials and methods

Study design and setting

This prospectively conducted multicenter observational cohort study was based on the Korean Hypothermia Network prospective registry (KORHN-PRO). The KORHN is a multicenter clinical research consortium for TTM in South Korea. Among 32 hospitals, 22 teaching hospitals throughout South Korea participated in this study and collected data from OHCA patients treated with TTM in advanced critical care settings. This study was approved by the institutional review boards of all participating hospitals and registered at the International Clinical Trials Registry Platform (NCT02827422). The Dong-A University Hospital Institutional Review Board (IRB) approved the study under entry code DAUHIRB-16-079. Written informed consent was obtained from all patients’ legal surrogates. The data were regularly monitored and reviewed by three clinical research associates, the investigator, and the clinical research coordinator of each site, with feedback from the investigator of the corresponding site. The 22 centers used a standardized TTM protocol across all sites, however, administration of vasoactive drugs and fluids and rewarming time were managed in accordance with institutional practices.

Study population

Among 10,258 cardiac arrest patients enrolled between October 2015 and December 2018, 1371 comatose survival patients were included. The inclusion criteria were as follows: patients over 18 years old, patients treated with mild therapeutic hypothermia after OHCA, and patients with an unconscious mental status (Glasgow Coma Scale < 8) after ROSC. Patients were excluded from the study who had rearrest events or death within 24 hours on admission (because TTM setting may be changed and missing data were increased), acute stroke (because TTM for 7 days was performed), a do not resuscitate (DNR) order, a prearrest cerebral performance category (CPC) score of 3 or 4, disease that would make survival at 6 months unlikely, a body temperature of <30°C on admission, and patients whose caregiver did not sign the written informed consent form.

Data collection

Blood pressure and heart rate were investigated every 6 hours for 4 days after ROSC via an arterial line or a noninvasive blood pressure cuff. SAP and DAP were examined and MAP was calculated from SAP and DAP. The time duration, maintenance dose, and total dose of vasopressors and inotropes including norepinephrine, vasopressin, dopamine, epinephrine, and dobutamine were recorded. The data on SAP, DAP, MAP, HR, and vasoactive agents were gathered from nurses’ records and chart reviews.

To consider the various confounding factors that are related to poor neurological outcome, basal demographic, resuscitation, and post-resuscitation variables were obtained from the prospective registry. Furthermore, various therapeutic procedures, such as percutaneous coronary intervention, renal replacement therapy, extracorporeal membrane oxygenator, and external cardiopulmonary resuscitation (E-CPR) that can influence neuroprognostication were additionally reviewed. The primary outcome was CPC scores, which were investigated by progress notes in each hospital or direct phone call to transferred hospitals or caregivers after 6 months; a CPC of 3 to 5 was considered a poor neurological outcome. Other risk scores for neuroprognostication, such as the Four score and cardiovascular sequential organ failure assessment (SOFA) score, were extracted and compared with the hemodynamic variables.

Hemodynamic variables

All the hemodynamic variables, including SAP, DAP, MAP, and HR, were compared for neuroprognostication in fixed time points (6 hour interval for 4 days), and the best combination was extrapolated from the relationship. We scrutinized the changes in blood pressure and HR according to time point. The hemodaynamic variables were measured for 4 days after ROSC, but cases who died one day after admission were regarded as missing hemodynamic variable data and the missing data were excluded in the analysis.

Statistical analysis

Descriptive statistics included percentages to summarize categorical variables and medians and interquartile ranges to summarize continuous variables. Inferential statistics included Fisher’s exact test to compare categorical variables and the Mann-Whitney U test to compare continuous variables. The risks associated with the level of DAP were assessed as odds ratios (ORs) according to time points using cubic spline models with 95% confidence intervals. Moreover, the accuracies of DAP and HR for neuroprognostication were compared over time. After the multivariable logistic regression analysis allowed for significant covariates, the adjusted OR regarding HR/DAP was analyzed. The discriminative ability of the hemodynamic variables for neuroprognostication was evaluated using receiver operating characteristic (ROC) curves with the corresponding area under the curve (AUC) and related sensitivity, specificity, and positive and negative predictive value.

Results

Participation and basal characteristics

Of 1371 patients assessed for eligibility, 943 patients (68.8%) had poor neurological outcomes while 428 patients (31.2%) had good neurologic outcomes and 794 patients (57.9%) died while 577 patients (42.1%) survived. Multivariable analysis was performed to test the multiplicative interaction in the association between the hemodynamic variables and a number of variables, such as basal demographic, resuscitation, and post-resuscitation variables. Significant variables included age, male sex, witnessed arrest, bystander CPR, low flow time, no flow time, prehospital ECG rhythm, causes of cardiac arrest, prearrest CPC, pupil reflex, GCS motor function, Four score, cardiovascular SOFA score, fluid balance, lactate, creatinine, and total dose of vasoactive agents (Table 1). The group with poor outcomes undoubtedly had poor neurologic examinations, more use of vasopressors, and more fluid administration. With allowance made for the statistically significant covariates, namely, age, sex, witnessed arrest, low flow time, shockable rhythm, pupil reflex, GCS motor, and lactate level, the risk of HR/DAP regarding poor outcome was superior to the cardiovascular SOFA score (adjusted OR 1.7 vs 1.279, Table 2).

Table 1

Baseline characteristics.

	All patients (n = 1371)	Good outcome (n = 428)	Poor outcome (n = 943)	p valuea
Age, years	62 (51–74)	58 (48–66)	65 (53–77)	<0.001
Male, n (%)	975 (71.1)	333 (77.8)	642 (68.1)	<0.001
BMI, kg/m 2	23.3 (20.9–25.7)	23.3 (21.3–25.6)	23.4 (20.8–25.7)	0.823
Witnessed arrest, n (%)	949 (70)	361 (84.5)	588 (63.3)	<0.001
Bystander CPR, n (%)	843 (62.4)	292 (69.2)	551 (59.3)	0.001
Time from arrest to CPR start, minutes	1 (0–7)	1 (0–5)	1 (0–8)	0.005
Time from CPR start to ROSC, minutes	15 (9–22.75)	15 (9–22.8)	31 (20–42)	<0.001
Time from ROSC to TTM start, hours	3.4 (2.2–4.9)	3.6 (2.5–5)	3.3 (2–4.8)	0.002
Prehospital ECG rhythm				<0.001
Asystole, n (%)	445 (37)	23 (6.1)	422 (51)
PEA, n (%)	269 (22.3)	54 (14.3)	215 (26)
Pulseless VT, n (%)	15 (1.2)	11 (2.9)	4 (0.5)
VF, n (%)	448 (37.2)	272 (72.1)	176 (21.3)
ROSC, n (%)	27 (2.2)	17 (4.5)	10 (1.2)
Previous history
Cardiovascular disease b , n (%)	285 (20.8)	99 (34.7)	186 (19.7)	0.152
Neurologic disease c , n (%)	138 (10.1)	27 (6.3)	111 (11.8)	0.002
Pulmonary disease, n (%)	106 (7.7)	13 (3)	93 (9.9)	<0.001
Malignancy, n (%)	80 (5.8)	23 (5.4)	57 (6)	0.465
Psychologic disease, n (%)	51 (3.7)	5 (1.2)	46 (4.9)	<0.001
Causes of cardiac arrest				<0.001
Medical, n (%)	851 (62.1)	479 (50.8)	372 (86.9)
Trauma, n (%)	28 (2)	2 (0.5)	26 (2.8)
Submersion, n (%)	19 (1.4)	4 (0.9)	2 (0.2)
Electrocution, n (%)	6 (0.4)	3 (0.5)	3 (0.4)
Drug overdose, n (%)	16 (1.2)	5 (1.2)	11 (1.2)
Asphyxia, n (%)	78 (5.7)	6 (1.4)	72 (7.6)
Hanging, n (%)	160 (11.7)	12 (2.8)	148 (15.7)
Others, n (%)	213 (15.5)	23 (5.4)	190 (20.1)
Pre-arrest CPC	1 (1–1)	1 (1–1)	1 (1–1)	<0.001
Pupil reflex, n (%)	643 (47.3)	346 (81)	297 (31.8)	<0.001
GCS motor, score	1 (1–1)	1 (1–3)	1 (1–1)	<0.001
Four score d	0 (0–3)	4 (0–7)	0 (0–1)	<0.001
Cardiovascular SOFAe at day 1	4 (2–4)	3 (0–4)	4 (3–4)	<0.001
Total dose of dopamine, μg	5605 (1650–21600)	2630 (1200–6060)	7800 (1882–22903)	<0.001
Total dose of norepinephrine, μg	108 (30–360)	46 (18–136.2)	150 (38.4–480)	<0.001
Total dose of vasopressin, IU	31 (7.2–113.4)	47 (16.4–291.2)	30.6 (7.2–108)	0.303
Total dose of epinephrine, μg	67.8 (18.3–270.8)	46.8 (9.9–153)	72 (22.2–294)	0.24
Total dose of dobutamine, μg	3600 (800–15970)	3360 (804–12908)	4200 (800–16709)	0.689
Input/Output at day 1, Ml	450 (-354–1725)	-114 (-744.8–756.3)	792 (-111–2117.8)	<0.001
Initial lactate, mg/dL	9.7 (6.1–12.9)	7.1 (4.3–10.9)	10.6 (7.5–13.6)	<0.001
Initial creatinine, mg/dL	1.3 (1.1–1.8)	1.2 (1–1.4)	1.4 (1.1–2.2)	<0.001
Target temperature, °C	33 (33–34)	33 (33–34)	33 (33–34)	0.445
Duration of TTM, hours	24 (24–24)	24 (24–24)	24 (24–24)	0.022
PCI, n (%)	206 (41.2)	117 (40.3)	89 (42.4)	0.713
RRT, n (%)	249 (18.3)	31 (7.3)	218 (23.3)	<0.001
ECMO, n (%)	48 (3.5)	21 (4.9)	27 (2.9)	0.08
ECPR, n (%)	15 (1.1)	2 (0.5)	13 (1.4)	0.167

Values are expressed as number (%) or median (interquartile range).

BMI denotes body mass index; CPR, cardiopulmonary resuscitation; ROSC, restoration of spontaneous circulation; TTM, targeted temperature management; PEA, pulseless electric activity; VT, ventricular tachycardia; PCI, percutaneous coronary intervention; RRT, renal replacement therapy; ECMO, extra-corporeal membrane oxygenation; ECPR, external cardiopulmonary resuscitation.

a The p value was calculated by means of Fisher’s exact test and the Mann-Whitney U-test.

b Cardiovascular disease included diseases such as cardiac arrest, coronary artery disease, and congestive heart failure.

c Neurological disease included diseases such as transient ischemic accident, stroke, and other neurological diseases.

d The four-scale score consisted of eye response, motor response, brainstem reflexes, and respiration and ranged from 0 to 4.

e Scores on the cardiovascular SOFA ranged from 0 to 4 (0, no hypotension; 1, MAP <70 mmHg; 2, dopamine ≤ 5 μg/kg/min or dobutamine; 3, dopamine > 5 μg/kg/min or epinephrine ≤ 0.1 μg/kg/min or norepinephrine ≤ 0.1 μg/kg/min; 4, dopamine > 15 μg/kg/min or epinephrine > 0.1 μg/kg/min or norepinephrine > 0.1 μg/kg/min).

Table 2

Multi-variable analysis to predict poor neurological outcome.

Standardized variables	Odds ratio	p value	95% CI
Age	1.911	<0.001	1.524–2.396
Male	0.783	0.022	0.635–0.965
Witnessed arrest	0.665	0.001	0.527–0.84
Time from CPR start to ROSC	3.296	<0.001	2.453–4.429
Shockable rhythm	0.403	<0.001	0.331–0.491
Pupil reflex	0.64	<0.001	0.511–0.8
GCS motor	0.673	<0.001	0.551–0.821
Four score	0.589	<0.001	0.47–0.738
Initial lactate	1.37	0.009	1.083–1.733
Cardiovascular SOFA	1.279	0.012	1.057–1.548
HR/DAP	1.7	<0.001	1.319–2.192

Hemodynamic parameters

Blood pressures and HRs at all time points for 4 days after ROSC were measured, and the predictive powers of these parameters are compared in Table 3. The predictive ability of DAP surpassed that of SAP and MAP at all time points, and neither SAP nor MAP were greater predictors than DAP (Table 3). The AUC and cut-off value of DAP at 0, 6, 12, 18, 24, 30, 36, 42, and 48 hours after ROSC were as follows: 0.632 and 71 mmHg; 0.598 and 65; 0.567 and 73; 0.557 and 56; 0.564 and 67; 0.573 and 65; 0.59 and 60; 0.585 and 62; and 0.585 and 62, respectively, and those of HR at 0, 6, 12, 18, 24, 30, 36, 42, and 48 hours after ROSC were as follows: 0.544 and 111 beats/min; 0.605 and 100; 0.662 and 73; 0.684 and 79; 0.656 and 72; 0.639 and 75; 0.65 and 83; 0.62 and 103; and 0.582 and 95, respectively. Compared with SAP, DAP, MAP, and HR, HR/DAP among all combinations of hemodynamic variables was the best predictor of neuroprognostication at all time points.

Table 3

Predictive accuracy of blood pressure and heart rate according to timing.

	Outcome	Sensitivity	Specificity	PPV	NPV	AUC
SAP in ROSC	Good	38.6	76.5	78.5	35.9	0.59
DAP in ROSC	Good	56	65.77	78.4	40.2	0.632
MAP in ROSC	Good	57.5	61.4	76.8	39.4	0.617
HR in ROSC	Poor	47.2	65.5	75.1	36	0.544
HR/DAP in ROSC	Poor	39.1	82.3	82.9	38	0.636
SAP in 6 hours	Good	44.8	70.4	76.5	37.2	0.588
DAP in 6 hours	Good	40.3	74.9	77.6	36.9	0.598
MAP in 6 hours	Good	46.6	70.9	77.5	38.2	0.601
HR in 6 hours	Poor	51.6	72.6	80.1	41.1	0.65
HR/DAP in 6 hours	Poor	51.6	72.6	80.1	41.1	0.65
SAP in 12 hours	Good	31.4	78.8	75.3	35.8	0.545
DAP in 12 hours	Good	40.3	73.8	76	37.5	0.567
MAP in 12 hours	Good	26.7	86.1	79.8	36.3	0.562
HR in 12 hours	Poor	71	54.2	76.2	47.5	0.662
HR/DAP in 12 hours	Poor	52.9	75.2	81.4	43.7	0.679
SAP in 24 hours	Good	19.1	91.4	81.8	36	0.542
DAP in 24 hours	Good	46.1	64.8	72.5	37.4	0.564
MAP in 24 hours	Good	32.9	80	76.8	37.2	0.559
HR in 24 hours	Poor	65.1	60.7	77	46.2	0.656
HR/DAP in 24 hours	Poor	47.1	79.3	82.1	42.8	0.666
SAP in 48 hours	Good	32.1	82	76.2	40.3	0.588
DAP in 48 hours	Good	54.4	65.7	73.9	44.6	0.628
MAP in 48 hours	Good	38.7	78	76	41.5	0.594
HR in 48 hours	Poor	49.7	65.6	72.1	42.1	0.582
HR/DAP in 48 hours	Poor	54.4	65.7	73.9	44.6	0.628
SAP in 72 hours	Good	46.2	68.2	70.6	43.5	0.569
DAP in 72 hours	Good	56.1	60	69.8	45.3	0.593
MAP in 72 hours	Good	45.4	70.9	72	44	0.587
HR in 72 hours	Poor	34.5	76	70.4	41.3	0.538
HR/DAP in 72 hours	Poor	52.7	62.5	69.9	44.5	0.591
SAP in 96 hours	Good	39.4	69	66.2	42.5	0.54
DAP in 96 hours	Good	69.1	45.3	66	48.8	0.576
MAP in 96 hours	Good	61.2	50.9	65.7	46	0.566
HR in 96 hours	Poor	33.1	74.7	67	41.9	0.526
HR/DAP in 96 hours	Poor	47.5	68.4	69.9	45.7	0.581

PPV denotes positive predictive value; NPV, negative predictive value; SAP, systolic arterial pressure; DAP, diastolic arterial pressure; MAP, mean arterial pressure: HR, heart rate.

Interestingly, the accuracies of DAP for neuroprognostication during TTM revealed an inverse U-shape, increasing and then decreasing, while those of HR showed a U-shape, decreasing and then increasing (Fig 1). DAP had lower prediction power of neurological outcome than HR for 2 days. Additionally, DAP < 55 to 70 mmHg for 2 days was associated with increased risks of poor neurologic outcome, but the risks of hypotension episodes were steeply increased up to 48 hours after ROSC and then gradually decreased 72 hours after ROSC (Fig 2). The risks of hypertension episodes were slightly exhibited over 72 hours after ROSC. Meanwhile, HR > 72–103 beats/min (cut-off) within 2 days after ROSC led to poor neurological outcomes, and the risk of HR > 70 to 100 beats/min was gradually restored after increasing for 2 days. Bradycardia or HR < 60 beats/min showed lower risks 6 hours to 24 hours after ROSC and higher risks at ROSC and more than 48 hours after ROSC (Fig 2). Bradycardia between 24 and 48 hours after ROSC had no effect on risk.

Fig 1

Accuracy of heart rate and diastolic arterial pressure changes to predict poor outcome according to time points.

Fig 2

Cubic spline models on diastolic arterial pressure and heart rate risks.

Discussion

The predictive ability of DAP for risk assessment was superior to that of SAP or MAP in cardiac arrest patients and HR/DAP or diastolic shock index among all hemodynamic variables was the best predictor of poor neurological outcomes at all time points. DAP < 55 to 70 mmHg and HR > 70 to 100 beats/min for 2 days after ROSC were correlated with poor neurological outcomes, HR < 60 beats/min 6 to 24 hours after ROSC showed a better outcome, and HR < 60 beats/min 48 hours after ROSC revealed a worse outcome.

DAP reflects vascular tone and arterial compliance [12]. This vascular tone or systemic vascular resistance (SVR) in cardiac arrest patients can be affected by post-resuscitation syndrome, including cardiac stunning and vasodilation, which may be maintained up to 72 hours [13]. “Sepsis”-like syndrome, which is also characterized by a systemic ischemic/reperfusion response, can occur in not only post-resuscitation syndrome or septic shock but also in cardiogenic shock [14, 15]. Simple hypovolemia might be more connected with SAP than DAP [16], however, diverse diseases or situations from sepsis, coronary ischemia, arrhythmia, or using vasopressor agents can combine in most cardiac arrest patients, and low blood pressure results from a certain combination of hypovolemic, cardiogenic, and distributed shock rather than pure shock. These multiplicative hemodynamics may influence DAP, reflecting vascular tone rather than SAP. The fact that the predictive ability of DAP may surpass that of SAP in reflecting hemodynamic status shows the probability that the diastolic shock index may be as available as the shock index or modified shock index.

The reason that DAP is a crucial factor in the heart and brain in cardiac arrest patients is as follows. DAP is a major determinant of coronary perfusion pressure, which is essential to retain adequate myocardial perfusion in the post-resuscitation phase [17]. In addition, a lower threshold of cerebral autoregulation is often shifted rightward in cardiac arrest patients. An MAP of 70 mmHg (MAP reflects twice as much DAP as SAP) may still result in brain hypoperfusion, even though it is within the normal range [18]. Therefore, maintaining a high normal DAP may help heart and brain resuscitation.

The predictive ability of DAP within 6 hours in cardiac arrest patients has been proven. Compared with SAP, MAP, and cardiovascular SOFA, DAP was a powerful predictor of poor neurological outcomes [3, 4]. In our results, the risk of poor outcome due to low DAP consistently soared for 2 days after ROSC and afterwards subsequently tapered off, but it still sustained a certain level of risk. Similar results are reported for septic shock. The ability of DAP to predict poor outcome in septic shock patients was superior to that of SAP and showed a similar performance to the SOFA score [5]. Higher DAP was a powerful predictor of in-hospital survival, compared with SAP [6]. Additionally, high DAP 72 hours after ROSC indicated a slight risk of poor outcome in our study. Chronic adaptation to hypertension might change the risks, as patients with a history of hypertension in hospital cardiac arrest showed good outcomes with high MAP, while patients without a history of hypertension showed poor outcomes with MAP > 115 mmHg [19].

Myocardial stunning can often induce low stroke volume and systolic and diastolic dysfunction, but reduced HR and increased SVR dominate the clinical hemodynamic effects of TTM [20]. Patients who underwent TTM maintained a lower HR and higher SVR during TTM than those who did not undergo TTM without a significant difference in MAP or stroke volume (SV) [21, 22]. Although a low HR may persist during TTM, acute onset tachycardia in this setting portends a worse outcome. In intensive care unit (ICU) patients, but not cardiac arrest patients, new onset prolonged sinus tachycardia as a consequence of sympathetic activity has been associated with increased major cardiovascular events and higher mortality rates [23]. Similar to ICU patients with tachycardia, but with a lower HR of over 72 to 83 beats/min due to functional hypothermia downregulation, cardiac arrest patients were related to a poor outcome, especially 2 days after ROSC. Studies in cardiac arrest patients demonstrated that a higher HR is connected with a poor outcome [8], and lower HR indicates a good outcome [21, 24, 25]. Cardiac arrest patients treated with TTM with a heart rate <60 beats/min or sinus bradycardia <50 beats/min have shown good outcomes 8 hours after ROSC or at any time during hypothermia [24, 25]; however, these results were only measured during the early phase of TTM. Bradycardia at 6 hours to 24 hours showed lower risks of a poor outcome in our data, but the risks gradually increased over 48 hours after ROSC.

The shock index (HR/SAP) has been associated with clinical outcomes in sepsis, septic shock, trauma, and cardiovascular disease [11]. Compared with the predictive ability of the shock index, that of the modified shock index is a better predictor of clinical outcome in most diseases other than hypovolemic shock [26, 27]. Even the modified shock index was similar or slightly superior to the shock index in predicting clinical outcome in trauma patients with hypovolemia [11, 28, 29]. The DAP or diastolic shock index in diseases with a complex interaction between various shock patterns would better reflect vasodilation than SAP or MAP [5]. Especially in septic shock patients, it has been demonstrated that the diastolic shock index is more effective in predicting clinical outcomes than the shock index [5]. Additionally, low DAP and high HR in patients with chronic AR are intimately connected with all causes of death, and the spline models of DAP and HR in the study correspond to our data [30]. The diastolic shock index in cardiac arrest has yet to be reported, and our results indicate that the diastolic shock index in cardiac arrest patients may have a pivotal role for risk assessment.

Limitations

Our study has several limitations. First, despite using the prospective multicenter registry of most variables, hemodynamic variables were recorded via chart records. This retrospective nature might be a limitation. Second, the group that did not undergo TTM was not included. The DAP and HR in cardiac arrest patients who did not undergo TTM that can induce lower HR and higher SVR can show different hemodynamic features. The pure changes and characteristics in DAP and HR due to cardiac arrest in the beginning must be studied. Third, the patients who survived 24 hours after ROSC were included in our study, but the hemodynamic data were omitted in the analysis: 87 patients who died within the first 24 hours and 265 patients who were missed according to time points. There was not much missing data. Finally, HR/DAP had low accuracy in predicting poor outcomes in cardiac arrest patients. Nonetheless, HR/DAP would be available for risk stratification and assessment or as a risk factor to predict poor neurological outcomes along with other significant variables.

Conclusions

Because TTM induces low HR and high SVR, increased HR and decreased DAP during TTM can be strongly linked with severe heart and brain damage. HR/DAP as a risk factor for poor neurological outcome in cardiac arrest patients was superior to SAP, MAP, HR, and cardiovascular SOFA score. DAP < 55 to 70 mmHg and HR > 70 to 100 beats/min for 2 days after ROSC were correlated with poor neurological outcome. Low DAP and high HR should be intensively monitored, especially for 2 days after ROSC, because hemodynamic changes at an early phase were associated with poor neurological outcome. Monitoring HR/DAP can help physicians guide the risk management of poor neurological outcomes in cardiac arrest patients.

5 Jul 2022

Heart Rate and Diastolic Arterial Pressure in Cardiac Arrest Patients: a Nationwide, Multicenter Prospective Registry

PLOS ONE

Dear Dr. Lee,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

15 Jul 2022

Title of the Manuscript: Heart Rate and Diastolic Arterial Pressure in Cardiac Arrest Patients: a Nationwide, Multicenter Prospective Registry

Manuscript Number: PONE-D-22-07847

I appreciate detailed and helpful comments and recommendations of the reviewer on the submitted manuscript. Considering the comments and recommendations, I revised the manuscript as below.

Reviewer: 1

This is an excellent review of shock indices and the role that DAP plays in neuroprognostication. I would include values for HR/DAP (along with HR/SAP, etc.) that offer the best prognostication, as this would make the study more applicable.

▶ Thank you very much. As you commented, I performed multi-variable analysis with significant variables and made table 2 newly. This study aimed to compare hemodynamic variables in cardiac arrest patients. I thought it might not need to deal with the risks of other variables on poor neurological outcome here. However, multi-variable analysis seems to make the result showed objectively.

One thing, it could be a problem that the statistical comparison and analysis of HR/DAP and HR/SAP can cause multicollinearity including the same or similar variable and so it was not conducted for the reason.

I would also consider adding a piece about mortality in your text about HR/DAP.

▶ I provided the information of survival rate in my text as below.

“Of 1371 patients assessed for eligibility, 943 patients (68.8%) had poor neurological outcomes while 428 patients (31.2%) had good neurologic outcomes and 794 patients (57.9%) died while 577 patients (42.1%) survived.”

23 Aug 2022

Heart rate and diastolic arterial pressure in cardiac arrest patients: a nationwide, multicenter prospective registry

PONE-D-22-07847R1

Dear Dr. Lee,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jignesh K. Patel

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

2 Sep 2022

PONE-D-22-07847R1

Heart rate and diastolic arterial pressure in cardiac arrest patients: a nationwide, multicenter prospective registry

Dear Dr. Lee:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jignesh K. Patel

Academic Editor

PLOS ONE